The great debate at "Immunotherapy Bridge 2018", Naples, November 29th, 2018

Paolo A Ascierto, Lisa H Butterfield, Sandra Demaria, Robert L Ferris, Gordon J Freeman, Roger S Lo, Alberto Mantovani, Paul Nathan, Omid Hamid, Katerina Politi, Igor Puzanov

Research output: Contribution to journalReview articlepeer-review


As part of the 2018 Immunotherapy Bridge congress (November 28-29, Naples, Italy), the Great Debate session featured counterpoint views from leading experts on four topical clinical issues in immunotherapy today. These were: the relative importance of adaptive versus innate immunity in the anti-cancer immune response; the merits of combination versus sequential immunotherapy regimens in the treatment of cancer; the advantages and disadvantages of murine models of cancer versus humans in order to evaluate immunotherapy; and whether or not mechanisms of resistance to immunotherapy differ between different cancers. Discussion of these important topics are summarised in this report.

Original languageEnglish
Pages (from-to)221
JournalJournal for ImmunoTherapy of Cancer
Issue number1
Publication statusPublished - Aug 15 2019


Dive into the research topics of 'The great debate at "Immunotherapy Bridge 2018", Naples, November 29th, 2018'. Together they form a unique fingerprint.

Cite this